Yuehua Li

Jiaotong University

H指数:12

被引数:1,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alkalinity and LSPR Effect-Based Cuproptosis Sensitizer to Reverse Tumor Microenvironment for Melanoma Therapy

基于碱度和LSPR效应的铜死亡敏化剂以逆转肿瘤微环境用于黑色素瘤治疗

Biomaterials

IF12.9

2025-12-130

PRE

Investigating the prognostic role of citrullination-related genes in breast cancer by combining transcriptomics, single-cell analysis and verification

通过整合转录组学、单细胞分析和验证，探究瓜氨酸化相关基因在乳腺癌中的预后作用。

The Breast

IF0

2025-09-250

OAAI

Pathological significance and therapeutic prospects of HCCS expression patterns in lung adenocarcinoma

HCCS表达模式在肺腺癌中的病理意义和治疗前景

Cell Adhesion & Migration

IF3.5

2025-07-040

TBL2 Promotes Tumorigenesis via PRMT5/WDR77-Mediated AKT Activation in Breast Cancer

TBL2通过PRMT5/WDR77-Mediated AKT激活促进乳腺癌的发生

ADVANCED SCIENCE

IF14.1

2024-11-050

Deciphering MOSPD1's impact on breast cancer progression and therapeutic response

BIOLOGY DIRECT

IF4.9

2024-10-050

OAAI

SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics

CELL BIOLOGY AND TOXICOLOGY

IF5.9

2024-06-260

OAAI

circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer

CANCER LETTERS

IF10.1

2024-06-017

PRE

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-04-192

OAAI

Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression

CANCER CELL INTERNATIONAL

IF6

2024-03-084

OAAI

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer

GPRC5A甲基化通过激活mTOR信号通路促进三阴性乳腺癌肝转移及多西他赛耐药

DRUG RESISTANCE UPDATES

IF21.7

2024-03-0150

OAAI

Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation

ENVIRONMENTAL RESEARCH

IF7.7

2023-12-015

PRE

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

乳腺癌靶向治疗和免疫治疗的临床进展

MOLECULAR CANCER

IF33.9

2023-07-06189

OAAI

A Pixel Circuit for Compensating Electrical Characteristics Variation and OLED Degradation

MICROMACHINES

IF3

2023-04-154

OAAI

Visible and NIR Image Fusion Based on Multiscale Gradient Guided Edge-Smoothing Model and Local Gradient Weight

IEEE SENSORS JOURNAL

IF4.5

2023-02-016

PRE

Design, synthesis and anti-gastric carcinoma activity of 1-styryl isoquinoline derivatives

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2022-09-012

PRE

Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma

具有巨大影响的小生物标志物: PI3K/AKT/mTOR信号和microRNA串扰调节鼻咽癌

BIOMARKER RESEARCH

IF11.5

2022-07-2625

OAAI

Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer

3-芳基异喹啉类拓扑异构酶 ⅰ 、 ⅱ 双重抑制剂的设计、合成及生物活性评价

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-07-018

PRE

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients

低CRIM1水平预测乳腺癌患者的不良预后

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-061

OAAI

An Information Retention and Feature Transmission Network for Infrared and Visible Image Fusion

用于红外和可见光图像融合的信息保留和特征传输网络

IEEE SENSORS JOURNAL

IF4.5

2021-07-018

PREAI

circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma

MOLECULAR MEDICINE REPORTS

IF3.5

2021-04-1921

OAAI

Yuehua Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向